Prevention and management of chemotherapy-induced nausea and vomiting.
about
Fosaprepitant dimeglumine for the management of chemotherapy-induced nausea and vomiting: patient selection and perspectivesEfficacy, safety and effectiveness of ondansetron compared to other serotonin-3 receptor antagonists (5-HT3RAs) used to control chemotherapy-induced nausea and vomiting: systematic review and meta-analysis.Moxibustion for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis.Chemotherapy-Induced Nausea and Vomiting: Incidence and Management in Jordan.The Most Common Side Effects Experienced by Patients Were Receiving First Cycle of Chemotherapy
P2860
Prevention and management of chemotherapy-induced nausea and vomiting.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Prevention and management of chemotherapy-induced nausea and vomiting.
@en
type
label
Prevention and management of chemotherapy-induced nausea and vomiting.
@en
prefLabel
Prevention and management of chemotherapy-induced nausea and vomiting.
@en
P2860
P1476
Prevention and management of chemotherapy-induced nausea and vomiting.
@en
P2093
Saeed Moradian
P2860
P304
216, 218-24
P356
10.12968/IJPN.2015.21.5.216
P50
P577
2015-05-01T00:00:00Z